Viewing Study NCT02236169


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2025-12-25 @ 8:44 PM
Study NCT ID: NCT02236169
Status: COMPLETED
Last Update Posted: 2014-09-10
First Post: 2014-09-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module